|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| License revenue | ||
| Operating expenses: | ||
| Research and development | ||
| General and administrative | ||
| Total operating expenses | ||
| Loss from operations | ||
| Other income (expense): | ||
| Interest income | ||
| Interest expense | ||
| Change in fair value of warrant liability | ||
| Change in fair value of investor rights and obligations liability | ||
| Other expense, net | ||
| Total other income, net | ||
| Income (loss) before income taxes | ||
| Provision for income taxes | ||
| Net loss | ||
| Other comprehensive income (loss): | ||
| Unrealized gain on marketable securities | ||
| Comprehensive loss | ||
| Net income (loss) attributable to common stockholders, basic | ||
| Net income (loss) attributable to common stockholders, diluted | ||
| Net loss per share, basic (in dollars per share) | ||
| Net loss per share, diluted (in dollars per share) | ||
| Weighted-average shares of common shares outstanding, basic (in shares) | ||
| Weighted-average shares of common shares outstanding, diluted (in shares) |
Loading...
